Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients

Jason L. Gaglia, Alexander Guimaraes, Mukesh Harisinghani, Stuart E. Turvey, Richard Jackson, Christophe Benoist, Diane Mathis, Ralph Weissleder

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.

Original languageEnglish (US)
Pages (from-to)442-445
Number of pages4
JournalJournal of Clinical Investigation
Volume121
Issue number1
DOIs
StatePublished - Jan 4 2011
Externally publishedYes

Fingerprint

Islets of Langerhans
Nanoparticles
Inflammation
Pancreas
Macrophage Activation
Autoimmune Diseases
Monocytes
Leukocytes
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gaglia, J. L., Guimaraes, A., Harisinghani, M., Turvey, S. E., Jackson, R., Benoist, C., ... Weissleder, R. (2011). Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. Journal of Clinical Investigation, 121(1), 442-445. https://doi.org/10.1172/JCI44339

Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. / Gaglia, Jason L.; Guimaraes, Alexander; Harisinghani, Mukesh; Turvey, Stuart E.; Jackson, Richard; Benoist, Christophe; Mathis, Diane; Weissleder, Ralph.

In: Journal of Clinical Investigation, Vol. 121, No. 1, 04.01.2011, p. 442-445.

Research output: Contribution to journalArticle

Gaglia, JL, Guimaraes, A, Harisinghani, M, Turvey, SE, Jackson, R, Benoist, C, Mathis, D & Weissleder, R 2011, 'Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients', Journal of Clinical Investigation, vol. 121, no. 1, pp. 442-445. https://doi.org/10.1172/JCI44339
Gaglia, Jason L. ; Guimaraes, Alexander ; Harisinghani, Mukesh ; Turvey, Stuart E. ; Jackson, Richard ; Benoist, Christophe ; Mathis, Diane ; Weissleder, Ralph. / Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. In: Journal of Clinical Investigation. 2011 ; Vol. 121, No. 1. pp. 442-445.
@article{465ca7e7cb9e4ac891419f7f6d272792,
title = "Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients",
abstract = "Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to {"}see{"} the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.",
author = "Gaglia, {Jason L.} and Alexander Guimaraes and Mukesh Harisinghani and Turvey, {Stuart E.} and Richard Jackson and Christophe Benoist and Diane Mathis and Ralph Weissleder",
year = "2011",
month = "1",
day = "4",
doi = "10.1172/JCI44339",
language = "English (US)",
volume = "121",
pages = "442--445",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients

AU - Gaglia, Jason L.

AU - Guimaraes, Alexander

AU - Harisinghani, Mukesh

AU - Turvey, Stuart E.

AU - Jackson, Richard

AU - Benoist, Christophe

AU - Mathis, Diane

AU - Weissleder, Ralph

PY - 2011/1/4

Y1 - 2011/1/4

N2 - Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.

AB - Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.

UR - http://www.scopus.com/inward/record.url?scp=78650967712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650967712&partnerID=8YFLogxK

U2 - 10.1172/JCI44339

DO - 10.1172/JCI44339

M3 - Article

VL - 121

SP - 442

EP - 445

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -